1.
Ferreira MHQ, Ribeiro RMP, Funes ABA, et al. Therapeutic action of the evolocumab monoclonal antibody against PCSK9 proteins in LDL cholesterol modulation: systematic review. Rev. Atenção Saúde. 2017;15(52):72-77. doi:10.13037/ras.vol15n52.4439